Global and China Precision Medicine Dynamic Monitoring and Future Investment Report 2023
- Report Code : ARS2753528
- Published On: Jul, 2023
- Category : Healthcare & Pharma
- Pages : 114
-
The report aims at estimating the market size and future growth potential of Precision Medicine market across different segments such as type, application and geography. The base year considered for the study is 2022, and the market size is forecast from 2023 to 2029.
The global Precision Medicine market size in 2022 is 7330.0 million US dollars, and it is expected to be XX million US dollars by 2029, with a compound annual growth rate of 12.60% expected in 2023-2029.
MARKET COMPETITIVE LANDSCAPE:
The main players in the Precision Medicine market include Moderna, Inc. (U.S.), Personalis, Inc. (U.S.), CureVac SE (Germany), Celldex Therapeutics (U.S.), and BioNTech SE (Germany). The share of the top 3 players in the Precision Medicine market is XX%.
REGION SHARE:
The report covers the market size information of North America, Europe, Asia Pacific, Latin America, Middle East and Africa, and North America accounted for XX%, Europe accounted for XX% of Precision Medicine market, and Asia Pacific accounted for XX%.
SEGMENT OVERVIEW:
The report segments the market by Type and Application. Pharmacogenomics accounted for XX% of Precision Medicine market in 2022. Point-of-Care Testing share of XX%.
Diagnostics accounted for XX% of the Precision Medicine market in 2022. Therapeutics accounts for XX%.
The research methodology used to estimate and forecast the Precision Medicine market begins by capturing data on key market player revenues through secondary research. The bottom-up procedure has been employed to arrive at the overall market size, by considering the revenue of key players in the market. After arriving at the overall market size, the total market has been split into several segments and sub-segments, which has been verified through primary research by conducting extensive interviews with key people such as industry experts, executives. This data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for segments and sub-segments.
This report provides the integrated ecosystem of the Precision Medicine market which offers holistic view of current demand and vendor side market. The research study answers several significant questions, primarily which market segments to focus on in next two to five years to prioritize factors such as resource effort, and investment.
Key Target audience:
Precision Medicine Manufacturers and Suppliers
Research and Development (R&D) Companies
Business Research and Consulting Service Providers
Research Organizations
Academic Centers and Universities Associations and Industrial Bodies
Technology Investors
The life sciences industry grows and continues to advance, driving innovation and improving healthcare outcomes for individuals around the world.
Artificial Intelligence (AI) and Machine Learning (ML): AI and ML technologies are increasingly being employed in life sciences research and development. They aid in drug discovery, optimizing clinical trials, analyzing vast amounts of biological data, and identifying patterns that can lead to breakthroughs in understanding diseases and developing new therapies.
Digital Health Technologies: Digital health technologies have seen rapid growth, especially in areas like telemedicine, wearable devices, and mobile health applications. These technologies enable remote patient monitoring, facilitate better healthcare access, and empower individuals to manage their health more effectively.
Wearable Devices and Remote Monitoring: Wearable devices, such as smartwatches and fitness trackers, have become more sophisticated, enabling continuous monitoring of vital signs and health parameters. These devices offer opportunities for early detection of health issues and improved management of chronic conditions.
Highlights-Regions
North America
United States
Canada
China
Asia Pacific (Excluding China)
Japan
Korea
Southeast Asia
India
Australia
EMEA
Europe
Germany
France
UK
Italy
Russia
Nordic
Middle East
Africa
Latin America
Brazil
Argentina
Mexico
Player list
Moderna, Inc. (U.S.)
Personalis, Inc. (U.S.)
CureVac SE (Germany)
Celldex Therapeutics (U.S.)
BioNTech SE (Germany)
Advaxis, Inc. (U.S.)
Agenus Inc. (U.S.)
Immatics Biotechnologies GmbH (Germany)
Gritstone Oncology (U.S.)
ImmunityBio, Inc. (U.S.)
bioMérieux SA (France)
Bayer AG (Germany)
Pfizer Inc. (U.S.)
GSK plc (U.K.)
F. Hoffmann-La Roche Ltd. (Switzerland)
Types list
Pharmacogenomics
Point-of-Care Testing
Stem Cell Therapy
Pharmacoproteomics
Others
Application list
Diagnostics
Therapeutics
Others
-
With tables and figures helping analyze worldwide Global and China Precision Medicine Dynamic Monitoring and Future Investment market, this research provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
Table of Content
1 Precision Medicine Market Introduction and Overview1.1 Precision Medicine Definition
1.2 Research Purposes
1.3 Currency Rate
1.4 Report Timeline
1.5 Economic Analysis of Global Regions
1.6 Inflation Analysis
2 Precision Medicine Business Cost Analysis2.1 Proportion of Manufacturing Cost Structure
2.1.1 Labor Cost
2.1.2 Operating Expenses2.2 Precision Medicine Industrial Chain Analysis
3 Market Competition by Manufacturers3.1 Global Precision Medicine Revenue and Market Share by Manufacturer
3.2 Manufacturers Precision Medicine Production Sites, Area Served, Product Types
3.3 Precision Medicine Market Competitive Situation and Trends
3.3.1 Precision Medicine Market Concentration Rate
3.3.2 Global Top 5 and Top 10 Players Market Share by Revenue in 2023
3.3.3 Mergers & Acquisitions, Expansion
4 Players Profiles4.1 Moderna, Inc. (U.S.)
4.1.1 Moderna, Inc. (U.S.) Company Profile
4.1.2 Precision Medicine Product Overview
4.1.3 Moderna, Inc. (U.S.) Precision Medicine Market Performance (2018-2023)
4.1.4 Moderna, Inc. (U.S.) Business Overview4.2 Personalis, Inc. (U.S.)
4.2.1 Personalis, Inc. (U.S.) Company Profile
4.2.2 Precision Medicine Product Overview
4.2.3 Personalis, Inc. (U.S.) Precision Medicine Market Performance (2018-2023)
4.2.4 Personalis, Inc. (U.S.) Business Overview4.3 CureVac SE (Germany)
4.3.1 CureVac SE (Germany) Company Profile
4.3.2 Precision Medicine Product Overview
4.3.3 CureVac SE (Germany) Precision Medicine Market Performance (2018-2023)
4.3.4 CureVac SE (Germany) Business Overview4.4 Celldex Therapeutics (U.S.)
4.4.1 Celldex Therapeutics (U.S.) Company Profile
4.4.2 Precision Medicine Product Overview
4.4.3 Celldex Therapeutics (U.S.) Precision Medicine Market Performance (2018-2023)
4.4.4 Celldex Therapeutics (U.S.) Business Overview4.5 BioNTech SE (Germany)
4.5.1 BioNTech SE (Germany) Company Profile
4.5.2 Precision Medicine Product Overview
4.5.3 BioNTech SE (Germany) Precision Medicine Market Performance (2018-2023)
4.5.4 BioNTech SE (Germany) Business Overview4.6 Advaxis, Inc. (U.S.)
4.6.1 Advaxis, Inc. (U.S.) Company Profile
4.6.2 Precision Medicine Product Overview
4.6.3 Advaxis, Inc. (U.S.) Precision Medicine Market Performance (2018-2023)
4.6.4 Advaxis, Inc. (U.S.) Business Overview
4.7 Agenus Inc. (U.S.)
4.7.1 Agenus Inc. (U.S.) Company Profile
4.7.2 Precision Medicine Product Overview
4.7.3 Agenus Inc. (U.S.) Precision Medicine Market Performance (2018-2023)
4.7.4 Agenus Inc. (U.S.) Business Overview
4.8 Immatics Biotechnologies GmbH (Germany)
4.8.1 Immatics Biotechnologies GmbH (Germany) Company Profile
4.8.2 Precision Medicine Product Overview
4.8.3 Immatics Biotechnologies GmbH (Germany) Precision Medicine Market Performance (2018-2023)
4.8.4 Immatics Biotechnologies GmbH (Germany) Business Overview
4.9 Gritstone Oncology (U.S.)
4.9.1 Gritstone Oncology (U.S.) Company Profile
4.9.2 Precision Medicine Product Overview
4.9.3 Gritstone Oncology (U.S.) Precision Medicine Market Performance (2018-2023)
4.9.4 Gritstone Oncology (U.S.) Business Overview4.10 ImmunityBio, Inc. (U.S.)
4.10.1 ImmunityBio, Inc. (U.S.) Company Profile
4.10.2 Precision Medicine Product Overview
4.10.3 ImmunityBio, Inc. (U.S.) Precision Medicine Market Performance (2018-2023)
4.10.4 ImmunityBio, Inc. (U.S.) Business Overview
4.11 bioMérieux SA (France)
4.11.1 bioMérieux SA (France) Company Profile
4.11.2 Precision Medicine Product Overview
4.11.3 bioMérieux SA (France) Precision Medicine Market Performance (2018-2023)
4.11.4 bioMérieux SA (France) Business Overview
4.12 Bayer AG (Germany)
4.12.1 Bayer AG (Germany) Company Profile
4.12.2 Precision Medicine Product Overview
4.12.3 Bayer AG (Germany) Precision Medicine Market Performance (2018-2023)
4.12.4 Bayer AG (Germany) Business Overview
4.13 Pfizer Inc. (U.S.)
4.13.1 Pfizer Inc. (U.S.) Company Profile
4.13.2 Precision Medicine Product Overview
4.13.3 Pfizer Inc. (U.S.) Precision Medicine Market Performance (2018-2023)
4.13.4 Pfizer Inc. (U.S.) Business Overview
4.14 GSK plc (U.K.)
4.14.1 GSK plc (U.K.) Company Profile
4.14.2 Precision Medicine Product Overview
4.14.3 GSK plc (U.K.) Precision Medicine Market Performance (2018-2023)
4.14.4 GSK plc (U.K.) Business Overview
4.15 F. Hoffmann-La Roche Ltd. (Switzerland)
4.15.1 F. Hoffmann-La Roche Ltd. (Switzerland) Company Profile
4.15.2 Precision Medicine Product Overview
4.15.3 F. Hoffmann-La Roche Ltd. (Switzerland) Precision Medicine Market Performance (2018-2023)
4.15.4 F. Hoffmann-La Roche Ltd. (Switzerland) Business Overview
5 Global Precision Medicine Historical and Forecast Market Analysis by Type5.1 Market Size Analysis by Types
5.2 Global Precision Medicine Revenue and Market Share by Type
5.3 Global Precision Medicine Revenue Market Forecast by Type (2023-2029)
6 Global Precision Medicine Historical and Forecast Market Analysis by Application6.1 Market Size Analysis by Application
6.2 Global Precision Medicine Revenue Market Share by Application (2018-2023)
6.3 Precision Medicine Revenue Market Forecast by Application (2023-2029)
7 Global Market Growth Trends Analysis7.1 Global Precision Medicine Market Size & Forecast (2018-2029)
7.2 Precision Medicine Growth Trends Analysis by Regions
7.2.1 Precision Medicine Market Size by Regions: 2018 VS 2023 VS 2029
7.2.2 Precision Medicine Historic Revenue Market Size by Regions (2018-2023)
7.2.3 Precision Medicine Forecasted Revenue Market Size by Regions (2023-2029)
7.2.4 North America Precision Medicine Market Size & Forecast (2018-2029)
7.2.5 EMEA Precision Medicine Market Size & Forecast (2018-2029)
7.2.6 China Precision Medicine Market Size & Forecast (2018-2029)
7.2.7 Asia-Pacific (Excluding China) Precision Medicine Market Size & Forecast (2018-2029)
7.2.8 Latin America Precision Medicine Market Size & Forecast (2018-2029)
8 North America8.1 North America Precision Medicine Revenue by Players
8.2 North America Precision Medicine Revenue by Types
8.3 North America Precision Medicine Revenue by Applications
8.4 North America Precision Medicine Market by Countries
8.4.1 North America Precision Medicine Revenue by Countries (2018-2029)8.5 North America SWOT Analysis
8.6 United States
8.7 Canada
9 China9.1 China Precision Medicine Revenue by Players
9.2 China Precision Medicine Revenue by Types
9.3 China Precision Medicine Revenue by Applications
9.4 China SWOT Analysis
9.5 China
10 Asia Pacific (Excluding China)10.1 Asia Pacific Precision Medicine Revenue by Players
10.2 Asia Pacific Precision Medicine Revenue by Types
10.3 Asia Pacific Precision Medicine Revenue by Applications
10.4 Asia Pacific Precision Medicine Market by Countries
10.4.1 Asia Pacific Precision Medicine Revenue by Countries (2018-2029)10.5 Asia Pacific SWOT Analysis
10.6 Japan
10.7 Korea
10.8 Southeast Asia
10.9 India10.10 Australia
11 EMEA11.1 EMEA Precision Medicine Revenue by Players
11.2 EMEA Precision Medicine Revenue by Types
11.3 EMEA Precision Medicine Revenue by Applications
11.4 EMEA Precision Medicine Market by Countries
11.4.1 EMEA Precision Medicine Revenue by Countries (2018-2029)11.5 EMEA SWOT Analysis
11.6 Europe
11.6.1 Europe Precision Medicine Revenue by Countries (2018-2029)
11.6.2 Germany
11.6.3 France
11.6.4 UK
11.6.5 Italy
11.6.6 Russia
11.6.7 Nordic
11.7 Middle East
11.8 Africa
12 Latin America12.1 Latin America Precision Medicine Revenue by Players
12.2 Latin America Precision Medicine Revenue by Types
12.3 Latin America Precision Medicine Revenue by Applications
12.4 Latin America Precision Medicine Market by Countries
12.4.1 Latin America Precision Medicine Revenue by Countries (2018-2029)12.5 Latin America SWOT Analysis
12.6 Brazil
12.7 Argentina
12.8 Mexico
13 Precision Medicine Industry Dynamic Analysis13.1 Precision Medicine Market Trends Analysis
13.2 Precision Medicine Market Drivers Analysis
13.3 Precision Medicine Market Challenges Analysis
13.4 Precision Medicine Market Restraints Analysis
14 Research Findings and Conclusion
-
The Global and China Precision Medicine Dynamic Monitoring and Future Investment Market has been segregated into various crucial divisions including applications, types, and regions. Each market segment is intensively studied in the report contemplating its market acceptance, worthiness, demand, and growth prospects. The segmentation analysis will help the client to customize their marketing approach to have a better command of each segment and to identify the most prospective customer base.
Report Objectives / Segmentation Covered :
By Companies / players:
By Regions:
By Type:
By Application:
Frequently asked questions(FAQ's):
Recognize the areas along the Global and China Precision Medicine Dynamic Monitoring and Future Investment Market's value chain where players are generating value. To get a complete picture, kindly read the entire report.
Depending upon the type of applications, the Global and China Precision Medicine Dynamic Monitoring and Future Investment Market has been segmented into
The Global and China Precision Medicine Dynamic Monitoring and Future Investment Market is expected to grow at a moderate CAGR during the forecast period of 2024 to 2029.
The convergence of various vital triggers, including a major slowdown in Western economies, and some critical points in globalization, leads to the transformation of business in the Global and China Precision Medicine Dynamic Monitoring and Future Investment Market across the extensive corporate landscape.
During the forecast years, the Global and China Precision Medicine Dynamic Monitoring and Future Investment Market can thrive with a robust CAGR.
